Alternative tools allowed the US Food and Drug Administration to avoid a substantial number of prior approval inspections during the coronavirus pandemic, potentially helping cement their use in the post-COVID-19 world.
Using Alternative Tools, US FDA Avoided Half Of ANDA Pre-Approval Inspections During Pandemic
Records reviews are common now in lieu of an in-person inspection for US generic applications, but more virtual facility checks could be coming soon.